US 10422807
Indirect homogeneous mobility shift assays for the detection of biologics in patient samples
granted A61PA61P1/04
Quick answer
US patent 10422807 (Indirect homogeneous mobility shift assays for the detection of biologics in patient samples) held by PRECISION IBD, INC. expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PRECISION IBD, INC.
- Grant date
- Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P1/04